151 related articles for article (PubMed ID: 23092025)
1. [Prospective follow-up of nebivolol in the treatment of arterial hypertension].
Despotović N; Matić-Cvetković D; Ivanović B
Srp Arh Celok Lek; 2012; 140(7-8):425-30. PubMed ID: 23092025
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
Germino FW; Lin Y; Pejović V; Bowen L
Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339
[TBL] [Abstract][Full Text] [Related]
4. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
von Fallois J; Faulhaber HD
Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
Lewin A; Punzi H; Luo X; Stapff M
Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and antihypertensive effect with nebivolol and losartan.
Van Bortel LM; Bulpitt CJ; Fici F
Am J Hypertens; 2005 Aug; 18(8):1060-6. PubMed ID: 16296572
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study.
Vaz-de-Melo RO; Giollo-Júnior LT; Martinelli DD; Moreno-Júnior H; Mota-Gomes MA; Cipullo JP; Yugar-Toledo JC; Vilela-Martin JF
Sao Paulo Med J; 2014; 132(5):290-6. PubMed ID: 25054966
[TBL] [Abstract][Full Text] [Related]
8. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
9. Nebivolol: impact on cardiac and endothelial function and clinical utility.
Toblli JE; DiGennaro F; Giani JF; Dominici FP
Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
[TBL] [Abstract][Full Text] [Related]
10. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
12. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
Lefebvre J; Poirier L; Poirier P; Turgeon J; Lacourciere Y
Br J Clin Pharmacol; 2007 May; 63(5):575-82. PubMed ID: 17094780
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
Merchant N; Searles CD; Pandian A; Rahman ST; Ferdinand KC; Umpierrez GE; Khan BV
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):720-5. PubMed ID: 20021529
[TBL] [Abstract][Full Text] [Related]
14. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
Papademetriou V
Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
[TBL] [Abstract][Full Text] [Related]
17. [Influence of nebivolol on left ventricular remodeling in patients with arterial hypertension without chronic heart failure].
Khurs EM; Zinov'eva IuA; Poddubnaia AV; Smolenskaia OG
Kardiologiia; 2007; 47(12):15-9. PubMed ID: 18260973
[TBL] [Abstract][Full Text] [Related]
18. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol: third-generation beta-blockade.
de Boer RA; Voors AA; van Veldhuisen DJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C
J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]